Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 296

1.

Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.

Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF.

Obstet Gynecol. 2012 Nov;120(5):1124-31. doi: http://10.1097/AOG.0b013e31825bc3b4.

PMID:
23090531
2.

Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.

Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF.

Gynecol Oncol. 2015 May;137(2):245-51. doi: 10.1016/j.ygyno.2015.03.007. Epub 2015 Mar 12.

PMID:
25773202
3.

Pathological findings in early-stage endometrial cancer.

Zehavi S, Schneider D, Bukovsky I, Halperin R.

Eur J Gynaecol Oncol. 2003;24(1):18-20.

PMID:
12691310
4.

Clinicopathologic analysis: relationship between endometrial carcinoma and uninvolved endometrium.

Dane C, Tatar Z, Dane B, Cetin A.

Eur J Gynaecol Oncol. 2009;30(1):71-4.

PMID:
19317261
5.
6.

Pure compared with mixed serous endometrial carcinoma: two different entities?

Roelofsen T, van Ham MA, Wiersma van Tilburg JM, Zomer SF, Bol M, Massuger LF, Bulten J.

Obstet Gynecol. 2012 Dec;120(6):1371-81. doi: http://10.1097/AOG.0b013e318273732e.

PMID:
23168762
7.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
8.

Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.

Gungorduk K, Ertas IE, Sahbaz A, Ozvural S, Sarica Y, Ozdemir A, Sayhan S, Gokcu M, Yilmaz B, Sanci M, Inan S, Harma M, Yildirim Y.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:147-52. doi: 10.1016/j.ejogrb.2014.05.040. Epub 2014 Jun 5.

PMID:
24965996
9.
10.

Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.

Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.

Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.

PMID:
19345400
11.

Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.

Bildrici K, Tel N, Ozalp SS, Yalcin OT, Yilmaz V.

Eur J Gynaecol Oncol. 2002;23(6):540-4.

PMID:
12556100
12.

Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.

Barlin JN, Soslow RA, Lutz M, Zhou QC, St Clair CM, Leitao MM Jr, Iasonos A, Hensley ML, Barakat RR, Matias-Guiu X, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Nov;23(9):1620-8. doi: 10.1097/IGC.0b013e3182a5055e.

13.

Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.

Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S.

J Obstet Gynaecol Res. 2010 Oct;36(5):1044-8.

PMID:
21058438
14.

Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.

Jiang XF, Tang QL, Li HG, Shen XM, Luo X, Wang XY, Lin ZQ.

J Obstet Gynaecol Res. 2013 Apr;39(4):855-63. doi: 10.1111/j.1447-0756.2012.02036.x. Epub 2012 Oct 29.

PMID:
23106983
15.

[Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type].

Stanojević Z, Dordević B.

Vojnosanit Pregl. 2006 Dec;63(12):1006-10. Serbian.

PMID:
17252704
16.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
17.

Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.

Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R.

Int J Gynecol Cancer. 2013 May;23(4):690-7. doi: 10.1097/IGC.0b013e31828c85c6.

PMID:
23518862
18.

[Clinical implications of positive peritoneal cytology in endometrial cancer].

Ren YL, Wang HY, Shan BE, Ping B, Shi DR.

Zhonghua Fu Chan Ke Za Zhi. 2011 Aug;46(8):595-9. Chinese.

PMID:
22169518
19.

[Synchronous primary cancers of the endometrium and ovary: review of 43 cases].

Ma SK, Zhang HT, Sun YC, Wu LY.

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):690-4. Chinese.

PMID:
19173912
20.

Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.

Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A, Demirhan B.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1412-8.

PMID:
16803539
Items per page

Supplemental Content

Write to the Help Desk